Skip to content

Ponoi Management, LLC

Follow

13F filer, CIK 1720702, San Francisco, CA

Ponoi Management, LLC reported $174,792,000 across 5 holdings for the quarter ended 2020-12-31, in a 13F-HR filed 2021-02-16.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-21-002048

Changes against Q3 2020 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Period
2020-12-31
Reported value
$175M
Holdings
5
Top 10 weight
100%
New
Sold out

Holdings, Q4 2020

Share positions as resolved from 13F-HR 0000950123-21-002048, largest first. % of portfolio is the value over $174,792,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,880,623 shares 1,880,623$54.2M30.99%
NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,298,908 shares 1,298,908$39.4M22.52%
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 1,599,417 shares 1,599,417$31.6M18.07%
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 685,011 shares 685,011$27.1M15.52%Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: restricted; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: 686,274 shares 686,274$22.6M12.91%Timeline

How Q4 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-21-002048 base2021-02-16acceptance time not in the bulk data set